Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.02)
# 1,834
Out of 4,512 analysts
58
Total ratings
64.3%
Success rate
15.4%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintained: Buy | $200 → $180 | $159.12 | +13.12% | 5 | Jul 6, 2026 | |
| RGEN Repligen | Maintained: Buy | $140 → $160 | $147.13 | +8.75% | 9 | Jul 6, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $410 | $357.65 | +14.64% | 8 | Jul 6, 2026 | |
| NTRA Natera | Maintained: Buy | $270 → $300 | $272.66 | +10.03% | 8 | Jul 6, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $118 → $90 | $74.59 | +20.66% | 6 | Jul 6, 2026 | |
| INSP Inspire Medical Systems | Downgraded: Hold | $55 → $40 | $49.15 | -18.62% | 8 | Jun 23, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $15.04 | +32.98% | 3 | Jun 5, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $71.23 | -29.80% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $74.12 | -8.26% | 1 | Nov 26, 2025 | |
| GH Guardant Health | Maintained: Buy | $68 → $90 | $160.11 | -43.79% | 4 | Oct 30, 2025 |
Insulet
Jul 6, 2026
Maintained: Buy
Price Target: $200 → $180
Current: $159.12
Upside: +13.12%
Repligen
Jul 6, 2026
Maintained: Buy
Price Target: $140 → $160
Current: $147.13
Upside: +8.75%
West Pharmaceutical Services
Jul 6, 2026
Maintained: Buy
Price Target: $410
Current: $357.65
Upside: +14.64%
Natera
Jul 6, 2026
Maintained: Buy
Price Target: $270 → $300
Current: $272.66
Upside: +10.03%
TransMedics Group
Jul 6, 2026
Maintained: Buy
Price Target: $118 → $90
Current: $74.59
Upside: +20.66%
Inspire Medical Systems
Jun 23, 2026
Downgraded: Hold
Price Target: $55 → $40
Current: $49.15
Upside: -18.62%
MiniMed Group
Jun 5, 2026
Maintained: Buy
Price Target: $20
Current: $15.04
Upside: +32.98%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $71.23
Upside: -29.80%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $74.12
Upside: -8.26%
Guardant Health
Oct 30, 2025
Maintained: Buy
Price Target: $68 → $90
Current: $160.11
Upside: -43.79%